These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20579276)

  • 1. Patient preferences and assessment of likely adherence to hepatitis C virus treatment.
    Brett Hauber A; Mohamed AF; Beam C; Medjedovic J; Mauskopf J
    J Viral Hepat; 2011 Sep; 18(9):619-27. PubMed ID: 20579276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicians' stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and Italy.
    Mohamed AF; Johnson FR; Hauber AB; Lescrauwaet B; Masterson A
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):419-26. PubMed ID: 22330238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment.
    Mühlbacher AC; Bridges JF; Bethge S; Dintsios CM; Schwalm A; Gerber-Grote A; Nübling M
    Eur J Health Econ; 2017 Mar; 18(2):155-165. PubMed ID: 26846922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.
    Johnson FR; Ozdemir S; Manjunath R; Hauber AB; Burch SP; Thompson TR
    Med Care; 2007 Jun; 45(6):545-52. PubMed ID: 17515782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient preferences for psoriasis treatments: process characteristics can outweigh outcome attributes.
    Schaarschmidt ML; Schmieder A; Umar N; Terris D; Goebeler M; Goerdt S; Peitsch WK
    Arch Dermatol; 2011 Nov; 147(11):1285-94. PubMed ID: 22106115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First and Foremost Battle the Virus: Eliciting Patient Preferences in Antiviral Therapy for Hepatitis C Using a Discrete Choice Experiment.
    Mühlbacher A; Bethge S
    Value Health; 2016; 19(6):776-787. PubMed ID: 27712705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained virologic response to treatment in 100% of patients recently infected, nosocomially, with HCV genotype 2.
    Sikuler E; Tur-Kaspa R; Shemer-Avni Y; Delgado J; Zilberman D; Fich A; Baruch Y; Hyam E
    J Clin Gastroenterol; 2008 Jul; 42(6):730-3. PubMed ID: 18574394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding HCV treatment to HIV treatment in HIV-HCV coinfected patients: the impact on the different dimensions of fatigue and self-reported side effects.
    Marcellin F; Préau M; Dellamonica P; Ravaux I; Kurkdji P; Protopopescu C; Carrieri MP; Spire B
    J Pain Symptom Manage; 2007 Oct; 34(4):413-21. PubMed ID: 17616331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient preferences for depression treatment programs and willingness to pay for treatment.
    Morey E; Thacher JA; Craighead WE
    J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The perspective of patients with haemophilia with inhibitors and their care givers: preferences for treatment characteristics.
    Brown TM; Pashos CL; Joshi AV; Lee WC
    Haemophilia; 2011 May; 17(3):476-82. PubMed ID: 21091851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders.
    Chainuvati S; Khalid SK; Kancir S; Shea M; Edwards J; Sernyak M; Wongcharatrawee S; Garcia-Tsao G
    J Viral Hepat; 2006 Apr; 13(4):235-41. PubMed ID: 16611189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter?
    Pacou M; Basso F; Gore C; Hass B; Taieb V; Cognet M; Pol S
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1063-8. PubMed ID: 26049711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and parent preferences for haemophilia A treatments.
    Mohamed AF; Epstein JD; Li-McLeod JM
    Haemophilia; 2011 Mar; 17(2):209-14. PubMed ID: 21070493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
    Poulos C; Kinter E; Yang JC; Bridges JF; Posner J; Reder AT
    Patient; 2016 Apr; 9(2):171-80. PubMed ID: 26259849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents.
    Hauber AB; Mohamed AF; Johnson FR; Falvey H
    Diabet Med; 2009 Apr; 26(4):416-24. PubMed ID: 19388973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' preferences for scoliosis brace treatment: a discrete choice experiment.
    Bunge EM; de Bekker-Grob EW; van Biezen FC; Essink-Bot ML; de Koning HJ
    Spine (Phila Pa 1976); 2010 Jan; 35(1):57-63. PubMed ID: 20023605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
    Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.
    John-Baptiste AA; Tomlinson G; Hsu PC; Krajden M; Heathcote EJ; Laporte A; Yoshida EM; Anderson FH; Krahn MD
    Am J Gastroenterol; 2009 Oct; 104(10):2439-48. PubMed ID: 19568230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
    Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
    Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.